Fig. 3From: Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort studyPropensity-score-weighted hazard ratios for composite CV event during as-treated follow-up period: Secondary comparisons. CI, confidence interval; CV, cardiovascular; DRV, darunavir; HR, hazard ratio; PI, protease inhibitorBack to article page